Evidence for HSP90 inhibition having a cytostatic effect on colon adenocarcinoma cells, rather than inducing cell death, suggests that HSP90 inhibitors used in combination with other agents can enhance tumour cell kill [178]. This evidence concerns the gene HSP90AA1 and colon adenocarcinoma.